Synklino is founded

Read more

Synklino is founded by Professor in Pharmacology at the University of Copenhagen, Mette M. Rosenkilde, Ph.d. in Protein Crystallography, Mads G. Jeppesen, and life science entrepreneur Thomas N. Kledal, PhD and MBA, who is the company CEO and former head of Virology DTU, Veterinary Institute, Technical University of Denmark. 

The team works on finding a better way to help organ and stem cell transplant recipients recover from transplantation, by developing a cure for frequent CMV infections otherwise causing increased mortality, prolonged hospitalization, and poor transplant outcome.